Readily
AI-native compliance platform for healthcare organizations, connecting regulations to internal policies.
Website: https://www.readily.ai/
Cover Block
Open sources
| Field | Value |
|---|---|
| Name | Readily |
| Tagline | AI-native compliance platform for healthcare organizations, connecting regulations to internal policies [readily.ai/about] |
| Headquarters | San Francisco, United States [ycombinator.com] |
| Founded | 2023 [ycombinator.com] |
| Stage | Series A [Citybiz, October 2026] |
| Business model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth profile | Venture Scale |
| Founding team | Co-Founders (2), Edward Tiong and Wei An Wang [ycombinator.com] |
| Funding label | Series A |
| Total disclosed funding | ~$11,500,000, based on a reported $500,000 seed in June 2023 and an $11 million Series A in October 2026 [jobswithstartups.com] [Citybiz, October 2026] |
Links
Open sources
- Website: https://www.readily.ai/
- Trust Center: https://trust.readily.ai/
- Y Combinator: https://www.ycombinator.com/companies/readily
- Jobs: https://www.workatastartup.com/companies/readily
What an Investor Needs First
PUBLIC Readily builds AI software for healthcare compliance teams, and it merits attention now because the company has moved from a Y Combinator-backed 2023 start to an $11 million Series A led by Define Ventures, a notable financing signal in a category where buyers feel persistent regulatory pressure [Y Combinator] [Citybiz, October 2026]. The company describes its platform as an AI-native compliance intelligence system that connects changing regulations to internal policies, assigned actions, audits, and supporting evidence, with an early wedge in labor-intensive work for health plans and Medicaid managed-care organizations rather than a broad horizontal assistant [readily.ai/about] [MedSpark, October 2026] [The SaaS News, October 2026].
The founding story is still lightly documented in public, but the outline is clear: Readily was founded in 2023 in San Francisco by Edward Tiong and Wei An Wang, and entered the Y Combinator S23 cohort shortly after formation [Y Combinator] [jobswithstartups.com]. On team quality, the public record is stronger for Tiong than for Wang. Y Combinator says Tiong studied AI at Berkeley, worked at Microsoft AI, and is a repeat founder, while Crunchbase and Beamstart tie him to prior healthtech and machine learning roles, including work at AKASA, which is relevant given Readily's payer-facing compliance focus [Y Combinator] [Crunchbase] [beamstart.com].
What stands out in the product is not novel model architecture, at least from public materials, but workflow specificity. Readily says the software compares new regulatory requirements against internal policies and contracts, identifies discrepancies and owners, drafts assessments and redlines, and links the work to evidence and audit readiness, which suggests the differentiation rests on structured compliance workflows inside healthcare rather than on the model layer alone [readily.ai/about] [readily.ai] [readily.ai/blog/readily-raises-11-million-series-a].
The funding picture is straightforward. Public sources indicate a $500,000 seed round in June 2023 and an $11 million Series A in October 2026 led by Define Ventures with participation from Y Combinator and the California Health Care Foundation Innovation Fund, and the company appears to sell on a SaaS basis into enterprise healthcare compliance functions [jobswithstartups.com] [Citybiz, October 2026] [The SaaS News, October 2026]. Public traction claims are directionally encouraging but remain mostly company-reported, including statements about reducing regulatory analysis, policy drafting, and audit work by up to 90 percent and a headcount of 20 employees based in San Francisco [workatastartup.com] [Y Combinator].
Over the next 12 to 18 months, the key watchpoints are whether Readily can convert company-reported efficiency outcomes into independently legible customer proof points, broaden beyond an initial Medicaid and payer compliance wedge without losing implementation clarity, and build trust around enterprise AI governance in a regulated environment where it already claims SOC 2 compliance and ISO 42001 certification [MedSpark, October 2026] [trust.readily.ai] [trust.readily.ai/?tab=faqs]. That is a credible setup, but the public record still leans heavily on company materials, so conviction depends less on category demand, which is evident, and more on proof of repeatable deployment and referenceable customer adoption.
Claim stands unchecked -- The section relies on a mix of independent funding coverage and company or platform-reported product, traction, and team claims, with several material operating details supported only by company-controlled sources.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Total disclosed approximately $11.5 million |
Inside the Company
PUBLIC
Readily enters a narrow but expensive part of healthcare operations: turning regulatory change into policy updates, assigned work, audit preparation, and evidence collection for compliance teams [readily.ai/about] [ycombinator.com]. The company was founded in 2023 and is headquartered in San Francisco, with Edward Tiong and Wei An Wang listed as co-founders on Y Combinator's company profile [ycombinator.com].
The public record is still compact, but the chronology is clear enough to sketch the early buildout. Y Combinator lists Readily in its S23 batch, which places the company in the 2023 cohort that often serves as the first external marker for formation and initial product development [ycombinator.com]. On its website, Readily describes the product as an "AI-native compliance intelligence platform" for healthcare organizations, with an initial focus on connecting regulatory requirements to internal policies and oversight workflows rather than offering a general-purpose assistant [readily.ai/about].
A second visible milestone came with outside financing. Jobs With Startups lists a $500,000 seed round in June 2023, and Citybiz reported an $11 million Series A in October 2026 led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund [jobswithstartups.com, June 2023] [Citybiz, October 2026]. That sequence suggests a company that moved from YC-era formation into a more clearly institutional funding profile while keeping its category definition tied to healthcare compliance rather than broader enterprise AI [ycombinator.com] [readily.ai/blog/readily-raises-11-million-series-a].
Partially corroborated -- Founded year, headquarters, and founding team are corroborated by Y Combinator and company materials, but funding chronology here relies in part on a single directory-style source for the seed round.
Under the Hood
Core product
MIXED The product is straightforward in concept and operationally specific in where it starts. Readily describes itself as an AI-native compliance intelligence platform for healthcare organizations that connects regulatory requirements to internal policies, assigned actions, audits, and supporting evidence [readily.ai/about]. Press coverage is directionally consistent on the workflow: the software scans new regulatory requirements, compares them against internal policies and contracts, and surfaces discrepancies, ownership, and completion status for compliance teams [readily.ai/about] [MedSpark, October 2026] [Citybiz, October 2026].
The company presents this less as a general assistant and more as a system for regulated work products. On its public materials, Readily says the platform can analyze audit requirements, cite supporting evidence, and draft assessments; identify policies affected by regulatory updates and produce redlined revisions; and collect and scrub delegate universes while flagging invalid records [readily.ai] [readily.ai/blog/readily-raises-11-million-series-a]. That combination suggests the product is trying to sit inside recurring compliance operations rather than only at the research layer, although the underlying performance claims remain company-reported rather than independently verified [workatastartup.com] [readily.ai].
Technical posture
MIXED Public evidence on the technical stack is limited, so the safer read is architectural posture rather than implementation detail. Readily's trust center says it has established AI data governance, tracks data lineage, performs data quality assessment and model validation, and monitors systems in production for performance and drift [trust.readily.ai] [trust.readily.ai/?tab=compliance]. The same trust materials state that the company is SOC 2 compliant and ISO 42001 certified, which matters because the product is being sold into regulated healthcare workflows where auditability and controls are part of the buying conversation, not an afterthought [trust.readily.ai/?tab=faqs].
What is still missing from the public record is equally important. There is no verified public demo in the supplied sources that establishes model architecture, deployment model, integration depth with payer systems, or whether human review is mandatory at each drafting step. The clearest public conclusion is that Readily is positioning the product around compliance traceability and evidence management, with AI used to accelerate regulatory analysis and document preparation inside that controlled workflow [readily.ai/about] [The SaaS News, October 2026].
Claim stands unchecked -- This section relies primarily on company website, trust center, and company press materials, with partial corroboration from trade coverage on product workflow and positioning.
Market Research
PUBLIC The market matters now because healthcare compliance work is becoming more document-heavy and more time-sensitive at the same moment that buyers are newly willing to test AI against narrow, auditable workflows, but the public record here supports the demand story more clearly than it supports a formal market size.
There is no cited third-party TAM, SAM, or SOM for Readily in the supplied research, so the cleaner way to frame the market is by starting from the buyer problem that multiple public sources do corroborate. Readily is positioned around healthcare organizations, with an emphasis on health plans and Medicaid managed-care organizations that need to interpret new rules, map them to internal policies and contracts, assign remediation, and remain audit-ready [Y Combinator] [readily.ai/about] [MedSpark, October 2026]. That is a specific operational slice of the broader governance, risk, and compliance software market, and more narrowly, the healthcare payer compliance workflow market. The distinction matters because the company is not presented as a general AI assistant for all back-office tasks, but as a system tied to regulatory analysis, policy management, audit preparation, and evidence capture [readily.ai/about] [Citybiz, October 2026].
The demand drivers in the cited research are practical rather than abstract. MedSpark's coverage points to payer teams processing extensive federal guidance and documentation, particularly in Medicaid managed care, which is consistent with Readily's stated wedge into labor-intensive regulatory and audit work for health plans [MedSpark, October 2026]. The company's own product descriptions also point to repetitive, rules-based tasks that have historically been handled by analyst teams, including scanning updates, identifying affected policies, comparing requirements with contracts, and drafting assessments or redlines [readily.ai/about] [readily.ai]. Even when company-reported impact figures such as up to 90 percent time reduction are treated conservatively, the underlying workflow burden is credible: these are high-frequency documentation tasks with direct consequences for audits, oversight, and plan operations [workatastartup.com].
Adjacent markets are easier to identify than hard market size because the product touches several existing software budgets. One adjacent market is healthcare policy and procedure management, where systems of record store internal policies but do not necessarily interpret incoming regulations. Another is audit and evidence management, where teams collect support for internal or external reviews. A third is broader enterprise GRC, especially where regulated organizations need traceability from requirement to control to evidence. Readily's own materials suggest it is trying to sit across those categories by linking regulatory requirements with policies, accountable actions, audits, and supporting evidence rather than selling into only one point solution budget [readily.ai/about] [readily.ai/blog/readily-raises-11-million-series-a].
The regulatory and macro backdrop also helps explain timing. Healthcare payers and provider-adjacent organizations face sustained compliance load from changing federal and state requirements, and Medicaid managed-care plans in particular operate in an environment where contract terms, oversight expectations, and reporting obligations can shift with policy updates [MedSpark, October 2026] [The SaaS News, October 2026]. At the same time, AI adoption in regulated settings still turns on governance and auditability, which makes Readily's public emphasis on data lineage, model validation, monitoring, SOC 2 compliance, and ISO 42001 certification commercially relevant if buyers are testing whether AI can be used in sensitive compliance workflows [trust.readily.ai] [trust.readily.ai/?tab=faqs]. Those claims remain company-supplied, but they align with what this buyer set would need before expanding usage.
| Market lens | What the public evidence supports | Source quality |
|---|---|---|
| Core market | Healthcare compliance software for health plans and related organizations, especially regulatory analysis and audit workflows | Mixed: company plus trade coverage |
| Initial wedge | Medicaid managed-care plan compliance and oversight work | Corroborated by trade coverage and company positioning |
| Adjacent budgets | Policy management, audit management, enterprise GRC | Analytical inference from product scope |
| Timing driver | Rising documentation burden plus narrower willingness to adopt AI for auditable workflows | Mixed: trade coverage plus company trust materials |
The table underscores the central limitation in the public record: the buyer pain and workflow category are reasonably legible, but formal market sizing is not. For investors, that means the market case rests less on a top-down TAM slide and more on whether this compliance wedge expands into a broader system of record for regulated healthcare operations.
Reasoned from indirect evidence -- Market structure and demand signals are partially corroborated by Y Combinator, MedSpark, The SaaS News, and Citybiz, but there is no independent third-party market sizing in the supplied research and several capability details are company-supplied.
Competition and Substitutes
Competitive positioning
MIXED Readily appears to be positioning itself less as a general healthcare AI assistant and more as workflow software for a narrow compliance problem, namely translating changing regulations into policy updates, audits, assigned actions, and evidence collection for health plans and related healthcare organizations [Y Combinator] [readily.ai/about] [MedSpark, October 2026].
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Readily | AI-native compliance platform for healthcare organizations | Series A, $11M announced in October 2026; prior $500K seed reported in June 2023 | Focus on linking regulatory requirements to internal policies, contracts, actions, audits, and evidence, with an initial wedge in health plan compliance workflows | [Citybiz, October 2026] [jobswithstartups.com] [readily.ai/about] [MedSpark, October 2026] |
| Adentris | Named competitor in structured research | Not established from the cited public materials provided | Competitive relevance is named in the research set, but public differentiation was not substantiated in the supplied sources | [Structured Facts] |
| Arctic Health | Named competitor in structured research | Not established from the cited public materials provided | Competitive relevance is named in the research set, but public differentiation was not substantiated in the supplied sources | [Structured Facts] |
| Hippocratic AI | Named competitor in structured research | Not established from the cited public materials provided | Competitive relevance is named in the research set, but the overlap appears adjacent rather than fully direct based on Readily's compliance-focused wedge | [Structured Facts] [MedSpark, October 2026] |
| Aegis | Named competitor in structured research | Not established from the cited public materials provided | Competitive relevance is named in the research set, but public differentiation was not substantiated in the supplied sources | [Structured Facts] |
The table points to a practical issue in this market map. Readily's own positioning is reasonably well described in public sources, while the named competitor set in the supplied record is thinly documented, which means the comparison is more reliable on Readily's side than on peers' exact product scope [readily.ai/about] [Citybiz, October 2026].
The competitive field can still be organized into three buckets. Incumbents are the internal compliance teams, policy teams, and audit functions inside health plans that still do much of this work through manual review, document comparison, and spreadsheet tracking, which is the substitute Readily is plainly trying to displace [MedSpark, October 2026] [readily.ai/about].
Readily's edge today is specificity. The company is not presenting itself as a broad clinical model company or a horizontal enterprise copilot, but as software for a narrow, expensive, recurring workflow inside regulated healthcare organizations, particularly health plans and Medicaid managed-care contexts [Y Combinator] [MedSpark, October 2026] [The SaaS News, October 2026]. That focus may matter because compliance work produces structured internal artifacts, policies, contracts, audits, ownership trails, and evidence, which are easier to anchor into a product system than open-ended assistant use cases [readily.ai/about]. The durability of that edge is still uncertain. If the advantage rests on workflow design, implementation knowledge, and trust controls such as SOC 2 compliance and ISO 42001 certification, it can compound over time; if it rests mainly on prompting and document summarization, it is perishable and easier for adjacent vendors to replicate [trust.readily.ai/?tab=faqs] [trust.readily.ai] [readily.ai/about].
The main exposure is that Readily does not appear to own an obvious proprietary distribution channel from the public record. Y Combinator and Define Ventures add credibility and access, but investor quality is not the same thing as embedded distribution into payer systems or mandated procurement pathways [Y Combinator] [Citybiz, October 2026]. That leaves room for a better-capitalized or better-connected rival to compress the window for customer acquisition, especially if one of the named competitors can pair comparable AI functionality with deeper existing relationships in compliance or broader enterprise healthcare software.
Over the next 18 months, the most plausible scenario is not a single winner-take-all outcome but a sorting between focused compliance vendors and adjacent AI platforms. Readily is the most credible winner if payer compliance teams continue to buy point solutions that reduce regulatory analysis and audit preparation time, because the company's public narrative is already tightly aligned to that pain point and supported by company-reported workflow outcomes [workatastartup.com] [readily.ai] [MedSpark, October 2026].
Reasoned from indirect evidence -- Readily's positioning is corroborated by multiple public sources, but the named competitor set and most peer-specific differentiation in this section rely on limited structured research rather than two-source public verification.
Opportunity
PUBLIC
The prize here is straightforward: if Readily becomes the system that large health plans use to translate regulatory change into policy updates, audits, and evidence collection, it could sit inside one of the least automated but most persistent cost centers in healthcare administration [Y Combinator] [readily.ai/about] [MedSpark, October 2026].
The headline opportunity is not general-purpose healthcare AI. It is narrower, and for that reason more believable. Readily is positioning around compliance operations for health plans, especially the work of interpreting new rules, mapping them to internal policies and contracts, assigning remediation, and preparing audit documentation [readily.ai/about] [MedSpark, October 2026] [The SaaS News, October 2026]. That wedge matters because the pain is recurring rather than discretionary, and because the company is selling into workflows where labor intensity appears high enough that even partial automation can matter. Public evidence is still early, but it is directionally supportive: the company has raised an $11 million Series A led by Define Ventures with participation from Y Combinator and the California Health Care Foundation Innovation Fund, and it is already presenting customer-level outcome claims around time savings and audit throughput, albeit company-reported rather than independently verified [Citybiz, October 2026] [readily.ai] [workatastartup.com].
A large outcome would likely come through a small number of distinct paths rather than a broad-based horizontal expansion. The scenarios below are the clearest public ones.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Health-plan system of record | Readily becomes the operating layer for regulatory analysis, policy revision, audit preparation, and evidence tracking across major payer compliance teams | The October 2026 Series A funds deeper product buildout and enterprise oversight capabilities [Citybiz, October 2026] | The product already spans regulations, policies, actions, audits, and evidence, which is closer to a system workflow than a point tool [readily.ai/about] [readily.ai/blog/readily-raises-11-million-series-a] |
| Medicaid compliance wedge to broader payer expansion | The company starts with Medicaid managed-care complexity, then expands into adjacent payer lines and enterprise compliance functions | A category-tipping reference customer inside managed care validates deployment beyond pilot use [MedSpark, October 2026] | Public coverage consistently frames Medicaid managed-care plans as the initial wedge, which suggests a focused entry point rather than a diffuse go-to-market [MedSpark, October 2026] [The SaaS News, October 2026] |
| Trust-led enterprise adoption | Readily converts AI governance and compliance posture into a procurement advantage with larger regulated customers | Enterprise buyers increasingly require formal AI controls, SOC 2, and governance documentation during vendor review [trust.readily.ai] | The company says it has SOC 2 compliance, ISO 42001 certification, AI data lineage tracking, model validation, and system monitoring in place, all of which can shorten diligence for risk-sensitive customers if verified in sales cycles [trust.readily.ai] |
The compounding mechanism, if it develops, would come from workflow depth rather than a classic consumer-style network effect. Each time Readily touches another part of the compliance chain, from regulatory ingestion to policy redlining to audit evidence, switching costs should rise because the product holds more of the reasoning trail and operational history inside one system [readily.ai] [readily.ai/about]. There is also a plausible data advantage. A platform that repeatedly compares regulations, contracts, policies, ownership assignments, and audit artifacts may improve its usefulness as it sees more examples of how health plans encode internal controls, though that remains an inference rather than a demonstrated moat. The early signal is simply that Readily is not describing a single-feature copilot. It is describing a connected workflow across multiple compliance tasks, and its hiring activity and 20-employee footprint suggest an organization still in build mode after financing [Y Combinator] [workatastartup.com] [Citybiz, October 2026].
The size of the win is difficult to anchor precisely because no public market-sizing data or directly comparable public peer was supplied in the available record. Even so, the upside case can be stated with discipline. If Readily were to become core compliance infrastructure for a meaningful share of large U.S. health plans, the result could resemble a category software asset with strategic value to larger healthcare IT, payer-services, or governance software buyers, rather than a feature vendor. The public inputs support that framing only at a high level: the company is pursuing a mandatory, recurring enterprise workflow in a heavily regulated segment, and investors have funded it accordingly at Series A scale [Citybiz, October 2026] [MedSpark, October 2026]. A reasonable public-side statement is that this could become a multi-hundred-million-dollar software outcome, or more, if the health-plan wedge expands into a durable system of record for compliance operations (scenario, not a forecast). The missing piece is external proof of breadth, retention, and budget authority, which is why the upside is real but still conditional.
Claim stands unchecked -- This section relies on a mix of independent funding coverage and company-supplied product, security, and outcome claims. The central upside thesis is plausible on public evidence, but several operational premises remain company-only and unverified.
Sources
Open sources
[Citybiz, October 2026] Readily Raises $11 Million Series A to Expand AI Healthcare Compliance Platform | https://www.citybiz.co/article/917816/readily-raises-11-million-series-a-to-expand-ai-healthcare-compliance-platform/
[Crunchbase] Edward Tiong - Crunchbase Person Profile | https://www.crunchbase.com/person/edward-tiong
[MedSpark, October 2026] Readily gathers $11M to read regulations for health plans | https://medspark.ai/2026/10/17/readily-gathers-11m-to-read-regulations-for-health-plans/
[The SaaS News, October 2026] Readily Raises $11M Series A | https://www.thesaasnews.com/news/readily-raises-11m-series-a/
[beamstart.com] Edward Tiong , Founder, Readily | BEAMSTART | https://beamstart.com/@edward-tiong-17464499635150
[jobswithstartups.com, June 2023] Readily | https://jobswithstartups.com/startups/readily
[readily.ai] Readily | AI-native compliance platform, built for healthcare | https://www.readily.ai/
[readily.ai/about] About Readily | Compliance intelligence for healthcare | https://www.readily.ai/about
[readily.ai/blog/readily-raises-11-million-series-a] Readily Raises $11 Million Series A to Expand AI Compliance Intelligence and Advance Enterprise Oversight for Healthcare | Readily | https://www.readily.ai/blog/readily-raises-11-million-series-a
[trust.readily.ai] Trust center | https://trust.readily.ai/
[trust.readily.ai/?tab=compliance] Trust center | https://trust.readily.ai/
[trust.readily.ai/?tab=faqs] Trust center | https://trust.readily.ai/
[workatastartup.com] Jobs at Readily (S23) | Y Combinator's Work at a Startup | https://www.workatastartup.com/companies/readily
[Y Combinator] Readily: AI Compliance Platform for Healthcare Organizations | Y Combinator | https://www.ycombinator.com/companies/readily
Articles about Readily
- Readily's AI Maps New Regulations to a Health Plan's Existing Policies — The Y Combinator-backed startup focuses on the labor-intensive audit work for Medicaid managed-care organizations, claiming 90% time savings.